Different effects of the BIM deletion polymorphism on treatment of solid tumors by the tyrosine kinase inhibitors (TKI) pazopanib, sunitinib, and lapatinib
Titel:
Different effects of the BIM deletion polymorphism on treatment of solid tumors by the tyrosine kinase inhibitors (TKI) pazopanib, sunitinib, and lapatinib
Auteur:
Spraggs, C.F. Parham, L.R. Song, K. Briley, L.P. Johnson, T. Russo, M. Tada, H. du Bois, A. Xu, C.-F.